Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression02:07

Tumor Progression

3.5K
3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hyaluronic acid targeted and pH-responsive nanocarriers based on hollow mesoporous silica nanoparticles for chemo-photodynamic combination therapy.

Colloids and surfaces. B, Biointerfaces·2020
Same author

Tumor phase recognition using cone-beam computed tomography projections and external surrogate information.

Medical physics·2020
Same author

Realization of a time-correlated photon counting technique for fluorescence analysis.

Biomedical optics express·2020
Same author

Ultrasonographic Diagnosis of Lipomatosis of Nerve: A Review of Ultrasonographic Finding for 8 Cases.

World neurosurgery·2020
Same author

Is dietary fat associated with the risk of age-related macular degeneration? Protocol for a systematic review and meta-analysis.

Medicine·2020
Same author

Comparing the Prevalence of Poor Sleep and Stress Metrics in Basic versus Advanced Life Support Emergency Medical Services Personnel.

Prehospital emergency care·2020
Same journal

Clonal evolution of mycosis fungoides into peripheral T-cell lymphoma: evidence from next-generation sequencing in two cases.

Annals of hematology·2026
Same journal

Delayed-onset parkinsonism possibly associated with elranatamab treatment for relapsed/refractory multiple myeloma: a case report of a poorly characterized neurological event.

Annals of hematology·2026
Same journal

Prognostic impact of KMT2A-PTD in acute myeloid leukemia in the NGS era: a multicenter retrospective study.

Annals of hematology·2026
Same journal

Flow cytometric analysis of T-cell subsets and platelet surface markers in patients with immune thrombocytopenia: a case-control study.

Annals of hematology·2026
Same journal

Lactate dehydrogenase (LDH) as a predictor of left atrial remodeling in patients with sickle cell anemia.

Annals of hematology·2026
Same journal

Pedigree analysis of cerebral venous sinus thrombosis associated with compound heterozygous hereditary protein S deficiency.

Annals of hematology·2026
See all related articles

Related Experiment Video

Updated: Mar 25, 2026

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.3K

FTO-CHRM3 axis regulates multiple myeloma progression: a machine learning-based identification.

Bo Lu1, Ting Bin1, Xue-Fei Deng1

  • 1Department of Haematology, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, 518000, China.

Annals of Hematology
|March 23, 2026
PubMed
Summary
This summary is machine-generated.

Fat Mass and Obesity-Associated (FTO) protein promotes multiple myeloma (MM) progression through the FTO-CHRM3 axis, impacting DNA replication and cell cycle. This research offers new therapeutic targets for MM.

Keywords:
CHRM3Calcium signaling pathwayFTOImmune microenvironmentMultiple myelomaSingle-cell RNA sequencing

More Related Videos

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.6K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.3K

Related Experiment Videos

Last Updated: Mar 25, 2026

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.3K
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.6K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.3K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Fat Mass and Obesity-Associated (FTO) gene is implicated in multiple myeloma (MM) progression.
  • The precise mechanisms of FTO's role in MM remain largely unknown.

Purpose of the Study:

  • To investigate the role and mechanisms of FTO in multiple myeloma (MM).
  • To identify FTO-associated genes and their impact on the MM immune microenvironment.

Main Methods:

  • Machine learning and correlation analyses to identify FTO-associated genes.
  • Immunohistochemistry to validate gene expression in MM tissues.
  • Immune infiltration and single-cell RNA sequencing (scRNA-seq) to analyze the immune microenvironment and cellular expression patterns.

Main Results:

  • FTO is upregulated in MM and linked to poor prognosis.
  • Identified CHRM3, GINS3, RRM2, and SHCBP1 as potential FTO-associated genes, with a focus on the FTO-CHRM3 axis.
  • FTO and CHRM3 are involved in DNA replication and cell cycle; altered M2 macrophage and eosinophil infiltration observed.
  • scRNA-seq revealed monocyte-specific SLC8A1 expression in the calcium signaling pathway.

Conclusions:

  • The FTO-CHRM3 axis drives MM progression through calcium signaling pathway dysregulation.
  • Understanding these mechanisms provides potential targets for MM interventions.